education_AdobeStock_©-Robert-Kneschke_251314673_2000px_191205

 

PM4Onco

PM4Onco - Personalized Medicine for Oncology

Duration of the project: May 2023 - April 2027

 

PM4Onco is a clinical use case funded by the Medical Informatics Initiative. The aim is to create a permanent infrastructure for integrating and exchanging data from clinical and biomedical research and so laying the foundations or establishing personalized medicine in cancer treatment.

The Research Group Data Management is involved in work package 7 of PM4Onco. The Charité has both an established Data Integration Centre (Phase 1 DIC) and an established Molecular Tumor Board and thus brings a wealth of experience in processes, structures and infrastructures to this working package. The Research Group Data Management supports the completion and integration of the necessary components and processes as well as the creation of operational software and documentation packages. It is also involved in the planning and implementation of the productive roll-out, i.e. implementing the infrastructure and connecting other newly established Data Integration Centres (Phase II DIC) with processes in the Molecular Tumor Board.

 

For more information visit the projects website: https://pm4onco.de/

 

PM4Onco_Logo

Latest News

SBHD 2024

Our colleagues at Vanderbilt University organise the 16th INTERNATIONAL CONFERENCE ON SYSTEMS BIOLOGY OF HUMAN DISEASE – SBHD 2024 this year from June 10-12. Don’t miss the opportunity to participate

Top 100 Köpfe der Wissenschaft 2023

Am 11.10.2023 wurde Prof. Roland Eils im Tagesspiegel als einer der 100 wichtigsten Köpfe der Hauptstadt-Wissenschaft gewürdigt. So schreibt der Tagesspiegel: "Um Big Data dreht sich alles in der

Young BIH scientists attend 72nd Lindau Nobel Laureate Meeting

The Lindau Nobel Laureate Meetings are annual conferences where some of the brightest minds in science converge to exchange knowledge, foster collaboration, and inspire the next generation of

Roland Eils wird als Highly Cited Researcher international gelistet.

Roland Eils gehört zu den weltweit am häufigsten zitierten Forschenden des Jahres 2022, wie aus der Liste der „Highly Cited Researchers“ hervorgeht, die das Unternehmen Clarivate heute veröffentlicht